Molecular imaging: Integration of molecular imaging into the musculoskeletal imaging practice

被引:32
作者
Biswal, Sandip
Resnick, Donald L.
Hoffman, John M.
Gambhir, Sanjiv S.
机构
[1] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA
[2] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA
[3] Univ Utah, Sch Med, Dept Radiol, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA
[5] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA
[6] Stanford Univ, Sch Med, Dept Bioengn, Mol Imaging Program, Stanford, CA 94305 USA
[7] Stanford Univ, Sch Med, BioX Program, Stanford, CA 94305 USA
关键词
D O I
10.1148/radiol.2443060295
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Chronic musculoskeletal diseases such as arthritis, malignancy, and chronic injury and/or inflammation, all of which may produce chronic musculoskeletal pain, often pose challenges for current clinical imaging methods. The ability to distinguish an acute flare from chronic changes in rheumat:oid arthritis,to survey early articular cartilage breakdown, to distinguish sarcomatous recurrence from posttherapeutic inflammation, and to directly identify genorators of chronic pain are a few examples of current diagnostic limitations. There is hope that a growing field known as molecular imaging will provide solutions to these diagnostic Puzzles. These techniques aim to depict, noninvasively, specific abnormal cellular, molecular, and physiologic events associated with these all other diseases. For example, the presence and mobilization of specific cell populations can be monitored with molecular imaging. Cellular metabolism, stress, and apoptosis can also be followed. Furthermore, disease-specific molecules can be targeted, and particular gene-related events. can be assayed in living subjects. Relatively recent molecular and cellular imaging protocols confirm important advances in imaging technology, engineering, chemistry, molecular biology, and genetics that have coalesced into a multidisciplinary and multimodality effort. Molecular probes are currently being developed not only or radionuclide-based techniques but also for magnetic resonance (MR) imaging, MR spectroscopy, ultrasonography, and the emerging field of optical imaging. Furthermore, molecular imaging is facilitating the development of molecular therapies and gene therapy, because molecular imaging makes it possible to noninvasively track and monitor targeted molecular therapies. Implementation of molecular imaging procedures will be essential to a clinical imaging practice. With this in mind, the goal of the following discussion is to promote a better understanding of bow such procedures may help address specific musculoskeletal issues, both now and in tile years ahead.
引用
收藏
页码:651 / 671
页数:21
相关论文
共 168 条
[1]   The role of nuclear medicine in primary bone and soft tissue tumors [J].
AbdelDayem, HM .
SEMINARS IN NUCLEAR MEDICINE, 1997, 27 (04) :355-363
[2]   Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography [J].
Adonai, N ;
Nguyen, KN ;
Walsh, J ;
Iyer, M ;
Toyokuni, T ;
Phelps, ME ;
McCarthy, T ;
McCarthy, DW ;
Gambhir, SS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :3030-3035
[3]   FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions [J].
Aoki, J ;
Watanabe, H ;
Shinozaki, T ;
Takagishi, K ;
Ishijima, H ;
Oya, N ;
Sato, N ;
Inoue, T ;
Endo, K .
RADIOLOGY, 2001, 219 (03) :774-777
[4]   Cytokines in the rheumatic diseases [J].
Arend, WP ;
Gabay, C .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (01) :41-+
[5]   Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis [J].
Barrera, P ;
van der Laken, CJ ;
Boerman, OC ;
Oyen, WJG ;
van de Ven, MTP ;
van Lent, PLEM ;
van de Putte, LBA ;
Corstens, FHM .
RHEUMATOLOGY, 2000, 39 (08) :870-874
[6]   Gd-DTPA(2-) as a measure of cartilage degradation [J].
Bashir, A ;
Gray, ML ;
Burstein, D .
MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (05) :665-673
[7]   The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis [J].
Bastiaannet, E ;
Groen, H ;
Jager, PL ;
Cobben, DCP ;
van der Graaf, WTA ;
Vaalburg, W ;
Hoekstra, HJ .
CANCER TREATMENT REVIEWS, 2004, 30 (01) :83-101
[8]   IMAGING RHEUMATOID-ARTHRITIS SPECIFICALLY WITH TC-99M CD4-SPECIFIC (T-HELPER LYMPHOCYTES) ANTIBODIES [J].
BECKER, W ;
EMMRICH, F ;
HORNEFF, G ;
BURMESTER, G ;
SEILER, F ;
SCHWARZ, A ;
KALDEN, J ;
WOLF, F .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 17 (3-4) :156-159
[9]  
Beckers C, 2004, J NUCL MED, V45, P956
[10]  
Beckmann N, 2003, MAGNET RESON MED, V49, P1047, DOI [10.1002/mrm.10480, 10.1002/mrm10480]